Fulcrum Therapeutics Inc.

NASDAQ: FULC · Real-Time Price · USD
6.81
0.21 (3.18%)
At close: Aug 15, 2025, 3:59 PM
6.82
0.15%
After-hours: Aug 15, 2025, 04:10 PM EDT

Fulcrum Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.72M -97.33M -109.87M -80.85M
Depreciation & Amortization
1.59M 2.17M 2.41M 2.52M
Stock-Based Compensation
14.55M 14.8M 13.35M 11.07M
Other Working Capital
-1.1M -3.45M -4.42M -13.61M
Other Non-Cash Items
-4.39M -5.99M 152K 673K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-4.25M -4.61M -3.09M -11.89M
Operating Cash Flow
-2.22M -90.97M -97.05M -78.48M
Capital Expenditures
-278K -508K -1.96M -1.71M
Cash Acquisitions
n/a n/a -14.38M 127.96M
Purchase of Investments
-178.59M -194.89M -151.15M -216.23M
Sales Maturities Of Investments
211.1M 158.71M 165.53M 88.28M
Other Investing Acitivies
n/a n/a 14.38M -127.96M
Investing Cash Flow
32.23M -36.69M 12.41M -129.67M
Debt Repayment
n/a n/a n/a -18K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.75M 777K 3.52M 3.67M
Financial Cash Flow
2.75M 118.12M 84.32M 186.51M
Net Cash Flow
32.76M -9.54M -314K -21.64M
Free Cash Flow
-2.5M -91.47M -99.01M -80.19M